Michael W. Dunne - Apr 1, 2023 Form 4/A - Amendment Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Michael W. Dunne
Stock symbol
ITRM
Transactions as of
Apr 1, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
6/5/2023, 08:00 AM
Date Of Original Report
Apr 3, 2023
Previous filing
Jan 4, 2023
Next filing
Jun 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ITRM Ordinary Shares Options Exercise $0 +1.3K +3.57% $0.00 37.6K Apr 1, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted share units ("RSUs") converted into ordinary shares on a one-for-one basis upon vesting of the RSUs.
F2 This amendment is being filed solely to correct an error in the Amount of Securities Beneficially Owned Following Reported Transaction in the original Form 4, as filed on April 3, 2023. The Amount of Securities Beneficially Owned Following Reported Transaction on April 1, 2023, which were reported as 37,636, should have been reported as 37,635.